Big blow for Teva as FDA approves Mylan's generic Copaxone - Globes
Teva's Copaxone holds its own in wake of Mylan's generic price cut | Fierce Pharma
Teva gains leverage in pursuit of Mylan | Pittsburgh Post-Gazette
Teva Pharmaceutical Industries' quest to acquire Mylan NV could wind up in a Dutch court - Pittsburgh Business Times
How Mylan tried to keep Teva from selling a generic EpiPen
Teva Pharmaceutical Industries Ltd. ends its hostile bid for Mylan NV - Pittsburgh Business Times
Mylan Raises Offer for Perrigo Again and Is Rejected Again - The New York Times
Teva drops bid for Mylan, buys Allergan's generics unit | Pittsburgh Post-Gazette
Teva wins FDA nod for its generic of Mylan's EpiPen after 2-year delay | Fierce Pharma
Mylan board rejects Teva takeover bid
Israel-Based Teva Pharmaceutical Industries Smacks Down With Mylan With $40B Bid - YouTube
Mylan surprises analysts, Teva with long-delayed Copaxone approvals | Fierce Pharma
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare IT News
Mylan Rejects Teva Takeover Bid As Too Low | Mint
Generic EpiPen Cleared By FDA As Teva Challenges Mylan
Mylan Should Try Teva On for Size - WSJ
Where a Teva-Mylan Deal Would Rank Among Big Pharma Companies
US lawmakers push Mylan, Teva over drug pricing probe - www.israelhayom.com
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats | Fierce Pharma
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Teva's Generic EpiPen Will Cost As Much As Mylan's Generic | Time
Teva Offers to acquire Mylan for $40 billion in cash, stock | Pharma Companies
Mylan, Generic Copaxone Punish Teva (NYSE:TEVA) | Seeking Alpha
FDA swats down Teva's EpiPen copy, putting Mylan in cruise control | Fierce Pharma
